However, when we studied the JAK2V617F allele burden in the CD34+ cells of 121 patients we found that men have higher allele burden independent of the specific MPN phenotype with the difference being more prominent in the lower-risk phenotypes of ET and PV [6]. The gene discussed is CD34; the disease is myeloproliferative neoplasm.